Crowdly
Add to Chrome
A researcher plans to use CRISPR/Cas9 for non-homologous end joining (NHEJ) in t...
✅ The verified answer to this question is available below. Our community-reviewed solutions help you understand the material better.
A researcher plans to use CRISPR/Cas9 for non-homologous end joining (NHEJ) in the mouse embryo. What is NOT part of the method?
❌
❌
❌
✅